South San Francisco biotechnology company Renovis, which slashed its workforce in January after one of its drug candidates flopped a major test, said Wednesday it has agreed to be purchased for $151.
From: www.mercurynews.com
Thursday, September 20, 2007
German drug maker to acquire Renovis
Posted by Ruslan Abuzant at 4:03 AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment